Cargando…

Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently

BACKGROUND: Factorial designs and multi-arm multi-stage (MAMS) platform designs have many advantages, but the practical advantages and disadvantages of combining the two designs have not been explored. METHODS: We propose practical methods for a combined design within the platform trial paradigm whe...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Ian R, Choodari-Oskooei, Babak, Sydes, Matthew R, Kahan, Brennan C, McCabe, Leanne, Turkova, Anna, Esmail, Hanif, Gibb, Diana M, Ford, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373200/ https://www.ncbi.nlm.nih.gov/pubmed/35579066 http://dx.doi.org/10.1177/17407745221093577

Ejemplares similares

Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
por: Blenkinsop, Alexandra, et al.
Publicado: (2019)

Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial
por: Choodari-Oskooei, Babak, et al.
Publicado: (2023)

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
por: Bratton, Daniel J., et al.
Publicado: (2016)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
por: Noor, Nurulamin M., et al.
Publicado: (2020)

Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
por: Gilson, C., et al.
Publicado: (2017)

The need for a cultural shift from two-arm to multi-arm RCTS
por: Sydes, Matthew R, et al.
Publicado: (2013)

Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate
por: Morris, Tim P, et al.
Publicado: (2019)

Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials
por: Noor, Nurulamin M, et al.
Publicado: (2022)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

Factorial versus multi‐arm multi‐stage designs for clinical trials with multiple treatments
por: Jaki, Thomas, et al.
Publicado: (2016)

The extension of total gain (TG) statistic in survival models: properties and applications
por: Choodari-Oskooei, Babak, et al.
Publicado: (2015)

Review and evaluation of performance measures for survival prediction models in external validation settings
por: Rahman, M. Shafiqur, et al.
Publicado: (2017)

RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse
por: Oza, Bhavna, et al.
Publicado: (2021)

Combined test versus logrank/Cox test in 50 randomised trials
por: Royston, Patrick, et al.
Publicado: (2019)

Estimands for factorial trials
por: Kahan, Brennan C., et al.
Publicado: (2022)

Re-randomisation trials in multi-episode settings: Estimands and independence estimators
por: Kahan, Brennan C, et al.
Publicado: (2022)

Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2011)

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
por: Royston, Patrick, et al.
Publicado: (2011)

Point estimation for adaptive trial designs II: practical considerations and guidance
por: Robertson, David S., et al.
Publicado: (2023)

Point estimation for adaptive trial designs I: A methodological review
por: Robertson, David S., et al.
Publicado: (2022)

Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
por: Kahan, Brennan C., et al.
Publicado: (2021)

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
por: Sydes, M R, et al.
Publicado: (2018)

Measuring the impact of methodological research: a framework and methods to identify evidence of impact
por: Brueton, Valerie C, et al.
Publicado: (2014)

Systematic review of available software for multi-arm multi-stage and platform clinical trial design
por: Meyer, Elias Laurin, et al.
Publicado: (2021)

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2012)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
por: Foltynie, Tom, et al.
Publicado: (2023)

Some recommendations for multi-arm multi-stage trials
por: Wason, James, et al.
Publicado: (2012)

Introduction to multi-armed bandits
por: Slivkins, Aleksandrs
Publicado: (2019)

Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing
por: Law, Martin, et al.
Publicado: (2023)

Correction: Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing
por: Law, Martin, et al.
Publicado: (2023)

The quality of outcome in anti‐reflux surgery is multi‐factorial
por: Attwood, Stephen E.
Publicado: (2022)

Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease
por: Wong, Charis, et al.
Publicado: (2022)

Multi-residue analysis of certain lanolin nipple care products for trace contaminants
por: Bourdillon, Katie, et al.
Publicado: (2023)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013)

The Smooth Away From Expected (SAFE) non-inferiority frontier: theory and implementation with an application to the D3 trial
por: Quartagno, Matteo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_drgalhtk3edjo42k5mo8d2bcha